The "XMU-GUYU Joint Research Center for Biomedicine," co-established by GUYU and Xiamen University, was recently inaugurated in Xiamen. Founded by Xiamen University alumnus Wang Anning, this collaboration exemplifies Xiamen's commitment to leveraging alumni resources for industry-academia-research integration. Academician Lin Shengcai of the Chinese Academy of Sciences, Professor at Xiamen University's School of Life Sciences, serves as the center's director. Academician Lin and his team pioneered the discovery of the AMPK-activated lysosomal pathway, whose activation correlates closely with health and longevity. As a benchmark enterprise in China's domestic skincare sector, GUYU has long focused on biotechnology R&D for skincare and whitening products. Through this partnership, GUYU will locate the joint center in Xiamen and invest RMB 12.5 million in R&D funding during the first five-year cooperation period to conduct fundamental research and tackle technical challenges in cutting-edge biomedical fields, accelerating the translation of scientific achievements into market applications.
